145
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE)

, , , , , , , , & show all
Pages 1503-1508 | Received 11 Aug 2018, Accepted 04 Nov 2018, Published online: 08 Jan 2019

References

  • Payen JL, Cales P. Gastric modifications in cirrhosis. Gastroenterol Clin Biol. 1991;15:285–295.
  • Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–1170.
  • Suit PF, Petras RE, Bauer TW, et al. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”. Am J Surg Pathol. 1987;11:750–757.
  • Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36:68–72.
  • Ward EM, Raimondo M, Rosser BG, et al. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol. 2004;38:898–900.
  • Calamia KT, Scolapio JS, Viggiano TR. Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol. 2000;18:605–608.
  • Ahn Y, Wang TK, Dunlop J. Treatment resistant gastric antral vascular ectasia in a patient undergoing haemodialysis. J Ren Care. 2014;40:263–265.
  • Patwardhan VR, Cardenas A. Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. Aliment Pharmacol Ther. 2014;40:354–362.
  • Roman S, Saurin JC, Dumortier J, et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy. 2003;35:1024–1028.
  • Spahr L, Villeneuve J-P, Dufresne M-P, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999;44:739–742.
  • Allamneni C, Alkurdi B, Naseemuddin R, et al. Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center. Eur J Gastroenterol Hepatol. 2017;29:973–976.
  • Saperas E, Perez-Ayuso RM, Poca E, et al. Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia. Am J Gastroenterol. 1990;85:138–144.
  • Quintero E, Pique JM, Bombi JA, et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology. 1987;93:1054–1061.
  • Sekar D, Venugopal B, Sekar P, et al. Role of microRNA 21 in diabetes and associated/related diseases. Gene. 2016;582:14–18.
  • Shi C, Huang F, Gu X, et al. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget. 2016;7:40830–40845.
  • Hackfort BT, Mishra PK. Emerging role of hydrogen sulfide-microRNA cross-talk in cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2016;10:H802–H812.
  • Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321–333.
  • Vlachos IS, Zagganas K, Paraskevopoulou MD, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460–W466.
  • Garcia DM, Baek D, Shin C, et al. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011;18:1139–1146.
  • Lu M, Kong X, Wang H, et al. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8:8775–8784.
  • Zhang J, Chong CC, Chen GG, et al. A seven-microRNA expression signature predicts survival in hepatocellular carcinoma. PLoS One. 2015;10:e0128628.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
  • Zeng L, Dai J, Ying K, et al. Identification of a novel human angiopoietin-like gene expressed mainly in heart. J Hum Genet. 2003;48:159–162.
  • Camenisch G, Pisabarro MT, Sherman D, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem. 2002; 277:17281–17290.
  • Koyama T, Ogawara K, Kasamatsu A, et al. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer. Cancer Med. 2015;4:759–769.
  • Zhu P, Goh YY, Chin HF, et al. Angiopoietin-like 4: a decade of research. Biosci Rep. 2012;32:211–219.
  • Le Jan S, Amy C, Cazes A, et al. Angiopoietin‐like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162:1521–1528.
  • Gealekman O, Burkart A, Chouinard M, et al. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab. 2008;295:E1056–E1064.
  • Tan MJ, Teo Z, Sng MK, et al. Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res. 2012;10:677–688.
  • El-Shal AS, Zidan HE, Rashad NM, et al. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma. Cytokine. 2017;96:75–86.
  • Albillos A, Colombato LA, Enriquez R, et al. Sequence of morphological and hemodynamic changes of gastric microvessels in portal hypertension. Gastroenterology. 1992;102:2066–2070.
  • Tan S, Chen X, Xu M, et al. receptor attenuated mucosal injury via β‐arrestin1/Src/EGFR‐mediated proliferation in portal hypertensive gastropathy. Br J Pharmacol. 2017;174:848–866. PGE2/EP4
  • Marlicz W, Wunsch E, Mydlowska M, et al. The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis. J Physiol Pharmacol. 2016;67:867–877.
  • Payen JL, Cales P, Pienkowski P, et al. Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil. J Hepatol. 1995;23:689–696.
  • Omair MA, Johnson SR. Gastric antral vascular ectasia unmasked by alprostadil for digital ulceration in scleroderma. J Rheumatol. 2011;38:784–785.
  • Kim SH, Park YY, Kim SW, et al. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011;71:7010–7020.
  • Xin X, Rodrigues M, Umapathi M, et al. Hypoxic retinal Muller cells promote vascular permeability by HIF‐1‐dependent up‐regulation of angiopoietin‐like 4. Proc Natl Acad Sci USA. 2013;110:E3425–E3434.
  • Yokouchi H, Eto K, Nishimura W, et al. Angiopoietin‐like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells. Acta Ophthalmol. 2013;91:E289–E297.
  • Kwon SH, Shin JP, Kim IT, et al. Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy. Ophthalmology. 2015;122:968–975.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.